ARTICLE
Auteur(s) : Gemma
Márquez Balbás, Angeles Sola Casas, Maribel Iglesias Sancho,
Manuel Sánchez-Regaña, Loida Galvany Rossell, Elisabet Dilmé
Carreras, Joaquim Sola Ortigosa, Pablo Umbert Millet
Dept of Dermatology, Dermatology Univesitary Hospital
Sagrat cor, Viladomat street 288, 08029 Barcelona, Spain
Mycosis fungoides palmaris en plantaris (MFPP) is a variant of
mycosis fungoides (MF) that presents primarily on the palms and
soles [1], and it has been infrequently described. Herein we report
three new cases of MF plantaris, each with a different clinical
form.
Case 1. A 63 year-old female presented a 1 year history of
multiple hyperkeratotic and fissured plantar plaques (figure 1A). She was
treated for plantaris hyperkeratosis resembling keratoderma with
topical corticosteroids and keratolytics, and oral acitretin, with
partial response. One 4 mm punch biopsy specimen was obtained from
the right foot, and it showed psoriasiform epidermal hyperplasia
and atypical lymphocytes with cerebriform nuclei (figure 1B). The
immunohistochemical study showed positivity for CD4
(> 70%).
Case 2. A 25-year-old male presented some brownish and
purple plaques, a little desquamative, on both feet (figure 1C). A punch
biopsy from the right foot was diagnostic for MF plantaris. The
skin biopsy showed a psoriasiform epidermal hyperplasia and focal
epidermotropism of cerebriform lymphocytes and Pautrier’s
micro-abscesses in some sections (figure 1D).
Immunohistochemical findings showed the infiltrate to be composed
mostly of CD4.
Case 3. A 43-year-old female presented a 2-year history of
an eczematous plantar plaque. It was pruritic and had not responded
to emollients and topical keratolytics (figure 1E). A biopsy
specimen from the lesion showed psoriasiform epidermal hyperplasia,
a band-like infiltrate containing numerous cerebriform lymphocytes
in the papillary dermis, and a single Pautrier’s micro-abscess
(figures 1F, G).
The immunohistochemical study showed a marked predominance of
CD4.
In all three cases a diagnosis of MF plantaris was established.
No other cutaneous involvement was observed, besides the plantar
lesions. In addition, extension studies were negative in all
patients. The first case is currently receiving treatment with
re-PUVA (acitretin 25 milligrams per day, and topical
8-metoxipsoralen and UVA), with a poor response after three months
of treatment. The second case presented clinical remission after
two months of treatment with topical clobetasol propionate 0.05%
and oral acitretin 25 mg/day. The third case also presented a
complete response with topical clobetasol propionate 0.05% after
six months of treatment. The last two cases have had a follow-up
period of almost 4 years.
MFPP is infrequent, about 0.6% of all MF [2]. Clinically, MFPP
mimics many other dermatoses. Cutaneous lesions may present as
multiple or single lesions, scaly and erythematous patches,
hyperkeratotic and dyshidrotic plaques [3, 4]. A wide clinical
spectrum is the reason why diagnosis of this entity is often
delayed. When the differential diagnosis is difficult, T
cell-receptor (TCR) gene rearrangement study is one of the most
useful methods for diagnosing MF [1]. In addition, clinical and
histological findings should be considered.
It is important to distinguish it from palmo-plantar involvement
in the course of a generalized MF, which is not uncommon. The
histopathological findings in a skin biopsy are indistinguishable
between these two entities. In single lesions, the most important
differential diagnosis is Woringer-Kolopp disease, which is
characterized by the presence of one or several scaly patches and
plaques with acral distribution. It is a benign T-cell
lymphoproliferative process with certain histological and
phenotypical similarities both to early epidemotropic mycosis
fungoides-type cutaneous T-cell lymphoma and other T-cell
lymphoproliferations.
In MFPP, various therapeutic modalities have been described with
PUVA [5], narrow band UVB [5], excision of solitary lesions [5],
high potency topical corticoids and intralesional corticoids,
methotrexate [5], bexarotene [5], radiotherapy [6], and electron
beam therapy [6], CO2 laser and topical nitrogen mustard [5].
This form of MF typically has a long benign course [4], no case
of extracutaneous spread has been described [5]. A skin biopsy
should be included in the study of all recalcitrant palmo-plantar
dermatoses, and MFPP considered in the differential diagnosis.
Acknowledgements
Financial support: none. Conflict of interest: none.
References
1 Kim ST, Jeon YS, Sim HJ, et al.
Clinicopathologic features and T-cell receptor gene rearrangement
findings of mycosis fungoides palmaris et plantaris. J Am Acad
Dermatol 2006; 54: 466-71.
2 M. Fernández-Guarino R. Carrillo-Gijón M. Fernández-Lorente C.
García-Millán E. Muñoz-Zato y P. Jaén-Olasolo. Placa
eritematoescamosa plantar. Actas Dermosifiliogr 2007; 98:
207-8.
3 Masmoudi S. Bouassida, A. Khabir, M. Loukil, J. Wechsler,
M. Bagot, T. Boudawara, H. Turki, A. Zahaf. Plaques
érythémato-squameuses palmo-plantaires. Ann Dermatol Venereol 2006;
133: 715-6.
4 Spieth K, Grundmann-Kollmann M, Runne U,
et al. Mycosis-fungoides-type cutaneous T cell lymphoma of the
hands and soles: a variant causing delay in diagnosis and adequate
treatment of patients with palmoplantar eczema. Dermatology 2002;
205: 239-44.
5 Laguna C, Pérez-Farriols A, Martín B. Alegre.
V. Placas hiperqueratósicas palmoplantares. Actas Dermosifiliogr
2007; 98: 565-6.
6 Resnik KS, Kantor GR, Lessin SR, et al.
Mycosis fungoides palmaris et plantaris. Arch Dermatol 1995; 131:
1052-6.
|